Jump to content
Sign in to follow this  

Clinical Trial for KRAS

Recommended Posts

KRAS Clinical Trial information: This trial is designed to evaluate how safe and effective the study drug known as abemaciclib is in participants with lung cancer. Specifically for people who have a confirmed diagnosis of stage IV non-small cell lung cancer (NSCLC) with a KRAS mutation and who have already received prior chemotherapy. http://www.lillytrialguide.com/juniper3

Share this post

Link to post
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
Sign in to follow this